Announcements Trials
Browse Landscape

Phase

Phase NA 46Phase 2 2Phase 3 1Phase 2/3 1Phase 1 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 1

Conditions

Lymphoma 2Hematologic Neoplasms 2Head and Neck Neoplasms 2Rectal Neoplasms 1Pain 1Neoplasms 1Mucositis 1Lymphoma, Large B-Cell, Diffuse 1Lymphedema 1Glioma 1Fallopian Tube Neoplasms 1Carcinoma in Situ 1Brenner Tumor 1Breast Neoplasms 1Anatomic Stage I Breast Cancer AJCC v8 1Abnormalities, Radiation-Induced 1

Interventions

Cyclophosphamide 149Docetaxel 138Paclitaxel 127Trastuzumab 119Tamoxifen 110Capecitabine 104Letrozole 92Epirubicin 79Doxorubicin 70Anastrozole 70exemestane 67Fulvestrant 65Fluorouracil 61Radiotherapy 60pertuzumab 40Gemcitabine 39Carboplatin 38Vinorelbine 34Goserelin 34Bevacizumab 29Zoledronic Acid 28Methotrexate 28Chemotherapy, Adjuvant 28eribulin 27Lapatinib 25ribociclib 24palbociclib 24Drug Therapy 22130-nm albumin-bound paclitaxel 20pegfilgrastim 19

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 3 × Breast Neoplasms × Methods × Clear all
NCT00376597 2026-05-18

Education With or Without Exercise and Counseling in Preventing Lymphedema in Women With Stage I, Stage II, or Stage III Breast Cancer Who Are Undergoing Axillary Lymph Node Dissection

Alliance for Clinical Trials in Oncology

Phase 3 Completed
568 enrolled 7 charts
Breast

Breast Neoplasms, Lymphedema

Data powered by HemOnc (CC BY 4.0) Colophon âš¡